Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 709 (USA) (Dr. Novak)
· consented 2014-01-18
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate OEDEMA PERIPHERAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-01 (study day 104.0); relationship: REMOTE
moderate
assessed
2026-08-18
Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-07 (study day 80.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.